Adjuvant Anti-Recurrence Treatment With Rapamycin on Early-stage HCC

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2012
To evaluate the clinical effect of rapamycin combined with TACE on early-stage HCC with overexpression of ASPH after radical surgery using randomized controlled study and provide a new anti-recurrence treatment for HCC patients after operation.
Epistemonikos ID: 8d8a4f08a6cbed7acc3cdf0f5dc2d066c828ec10
First added on: May 12, 2024